Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accompanying patients in clinical oncology teams: Reported activities and perceived effects.
Pomey MP, Paquette J, Iliescu-Nelea M, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. Health Expect. 2023 Apr;26(2):847-857. doi: 10.1111/hex.13710. Epub 2023 Jan 26. Health Expect. 2023. PMID: 36704843 Free PMC article.
An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress.
Pomey MP, Nelea MI, Normandin L, Vialaron C, Bouchard K, Côté MA, Duarte MAR, Ghadiri DP, Fortin I, Charpentier D, Lavoie-Tremblay M, Fernandez N, Boivin A, Dorval M, Desforges M, Régis C, Ganache I, Bélanger L, Rosberger Z, Danino MA, Pelletier JF, Vu TTT, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Cancer. 2023 Apr 22;23(1):369. doi: 10.1186/s12885-023-10856-9. BMC Cancer. 2023. PMID: 37087438 Free PMC article.
Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors.
Pomey MP, Paquette J, Nelea MI, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Vachon MF, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Health Serv Res. 2024 Jan 30;24(1):150. doi: 10.1186/s12913-024-10624-w. BMC Health Serv Res. 2024. PMID: 38291443 Free PMC article.
The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients' point of view.
Pomey MP, Iliescu Nelea M, Vialaron C, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Adjtoutah N, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Cancer. 2024 Jul 10;24(1):822. doi: 10.1186/s12885-024-12585-z. BMC Cancer. 2024. PMID: 38987731 Free PMC article.
Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.
Serban M, Spampinato S, de Leeuw A, Fortin I, Kirisits C, Ye XY, Schmid M, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Bhavana R, Cooper R, Steen Banasik E V, Limbergen EV, Pieters BR, Tan LT, Chopra S, Nout R, Nesvacil N, Kirchheiner K, Pötter R, Jürgenliemk-Schulz IM, Tanderup K. Serban M, et al. Among authors: fortin i. Radiother Oncol. 2025 Sep;210:110954. doi: 10.1016/j.radonc.2025.110954. Epub 2025 May 29. Radiother Oncol. 2025. PMID: 40449684
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer.
Knoth J, Nout RA, Pötter R, Mahantshetty U, Jürgenliemk-Schulz I, Haie-Meder C, Fortin I, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, Haverkort MAD, van Limbergen E, Pieters BR, Tan LT, Boryshchuk D, Ristl R, Hawaldar R, Kannan S, de Leeuw AAC, Eder-Nesvacil N, Tanderup K, Kirisits C, Lindegaard JC, Schmid MP. Knoth J, et al. Among authors: fortin i. Int J Radiat Oncol Biol Phys. 2025 Oct 1;123(2):503-512. doi: 10.1016/j.ijrobp.2025.04.037. Epub 2025 May 10. Int J Radiat Oncol Biol Phys. 2025. PMID: 40354949 Free article.
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
41 results